151 related articles for article (PubMed ID: 15376243)
1. Combined millimeter wave and cyclophosphamide therapy of an experimental murine melanoma.
Logani MK; Bhanushali A; Anga A; Majmundar A; Szabo I; Ziskin MC
Bioelectromagnetics; 2004 Oct; 25(7):516-23. PubMed ID: 15376243
[TBL] [Abstract][Full Text] [Related]
2. Effect of millimeter waves on natural killer cell activation.
Makar VR; Logani MK; Bhanushali A; Kataoka M; Ziskin MC
Bioelectromagnetics; 2005 Jan; 26(1):10-9. PubMed ID: 15605409
[TBL] [Abstract][Full Text] [Related]
3. Effect of millimeter waves on cyclophosphamide induced suppression of the immune system.
Logani MK; Anga A; Szabo I; Agelan A; Irizarry AR; Ziskin MC
Bioelectromagnetics; 2002 Dec; 23(8):614-21. PubMed ID: 12395417
[TBL] [Abstract][Full Text] [Related]
4. Effect of millimeter wave irradiation on tumor metastasis.
Logani MK; Szabo I; Makar V; Bhanushali A; Alekseev S; Ziskin MC
Bioelectromagnetics; 2006 May; 27(4):258-64. PubMed ID: 16437545
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclophosphamide and 61.22 GHz millimeter waves on T-cell, B-cell, and macrophage functions.
Makar VR; Logani MK; Bhanushali A; Alekseev SI; Ziskin MC
Bioelectromagnetics; 2006 Sep; 27(6):458-66. PubMed ID: 16622862
[TBL] [Abstract][Full Text] [Related]
6. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
[TBL] [Abstract][Full Text] [Related]
7. Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
Huang Z; Raychowdhury MK; Waxman DJ
Cancer Gene Ther; 2000 Jul; 7(7):1034-42. PubMed ID: 10917206
[TBL] [Abstract][Full Text] [Related]
8. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
[TBL] [Abstract][Full Text] [Related]
9. Effect of millimeter waves on cyclophosphamide induced suppression of T cell functions.
Makar V; Logani M; Szabo I; Ziskin M
Bioelectromagnetics; 2003 Jul; 24(5):356-65. PubMed ID: 12820293
[TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Zheng LM; Li Z; Liu L; Song BL; King I
Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
[TBL] [Abstract][Full Text] [Related]
12. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
[TBL] [Abstract][Full Text] [Related]
14. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models.
Streck CJ; Dickson PV; Ng CY; Zhou J; Gray JT; Nathwani AC; Davidoff AM
Clin Cancer Res; 2005 Aug; 11(16):6020-9. PubMed ID: 16115947
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline potentiates antitumor effect of cyclophosphamide in mice.
Chhipa RR; Singh S; Surve SV; Vijayakumar MV; Bhat MK
Toxicol Appl Pharmacol; 2005 Feb; 202(3):268-77. PubMed ID: 15667832
[TBL] [Abstract][Full Text] [Related]
18. Cytological aspects of rat mammary cancer therapy with soluble tumor-associated antigens and anticancer drugs.
Zusman I
Med Sci Monit; 2005 May; 11(5):RA173-181. PubMed ID: 15874908
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between millimeter wave irradiation in pregnant mice and c-Fos protein expression in hippocampus and learning and memory functions in their offsprings].
Zhao ZG; Zhang JF; Yan P; Ma YM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Dec; 23(6):424-7. PubMed ID: 16405774
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
